The critical shortage of organs for transplant impacts thousands of patients each year, but a recent scientific breakthrough offers a potential long-term solution. Researchers have overcome a major obstacle in developing human-animal chimeras – organisms containing both human and animal cells – paving the way for growing human organs within animals for transplantation. This advance, detailed in the journal cell, centers on disabling a key protein that previously triggered the host animal’s immune system to reject human cells, offering renewed hope in the field of xenotransplantation and a possible end to lengthy donor waitlists.
The wait for organ donors may soon be a thing of the past. Scientists are pushing the boundaries of what’s possible with a new breakthrough: successfully growing human cells inside animals. This represents a significant step toward transforming the medical field and addressing the critical shortage of organs available for transplant worldwide.
This process, known as a chimera – or a hybrid organism containing cells from both humans and animals – offers a potential source for replacement organs. However, significant hurdles have historically hampered progress, until now.
Understanding Chimeras: When Human and Animal Cells Combine
The term chimera often evokes images of mythical creatures with multiple heads, but in scientific terms, it refers to a single organism composed of cells with two distinct genetic makeups. This phenomenon occurs naturally (as seen in cases of conjoined twins).
What the medical community is striving to develop is interspecies chimerism – creating chimeras across species. As early as 2017, scientists successfully created a human-pig chimera, hoping to utilize these animals as a source of organs for transplantation. However, for the past eight years, the process has consistently failed because the host animal’s immune system – specifically, a strong innate RNA immunity – aggressively rejected the human cells, preventing them from growing and integrating to form organs.
Unlocking the Secret: The MAVS Protein as a Key to Success
A pivotal breakthrough came with recent research published in the prestigious journal Cell. A team of biologists at UT Southwestern in Texas discovered that the primary obstacle was a protein within animal cells called MAVS.
Researchers found that disabling the MAVS protein effectively shut down the animal’s immune system’s alarm signals. This allowed human cells to survive rejection, compete with and integrate into the animal embryo effectively, and ultimately, facilitated the more complete development of human organs within the animal host. This discovery represents a major step forward in the field of xenotransplantation.
The research team further refined the technique by using Nanobodies to modify the surface of human stem cells, improving their ability to adhere to cells from different species and overcoming natural connectivity issues.
While the creation of human-animal chimeras (typically containing less than 10% human cells) remains ethically sensitive and faces opposition from animal rights groups, xenotransplantation is rapidly advancing. In March 2024, Massachusetts General Hospital successfully transplanted a genetically modified pig kidney into a living patient for the first time.
More recently, NYU Langone Health initiated trials to transplant organs from other species into patients with end-stage renal cancer.
This success in unlocking a fundamental biological mechanism marks a significant milestone, demonstrating science’s ability to overcome previous limitations. However, the creation of hybrid organisms continues to be a delicate issue that society must address.
Ultimately, the future of this technology may depend not only on laboratory capabilities but also on finding a balance between the urgent need to save human lives and establishing appropriate ethical boundaries. This is a complex challenge that requires collaboration between the medical community, legal experts, and society as a whole.
à¸à¹‰à¸²à¸‡à¸à¸´à¸‡: popularmechanics
